Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review

Checkpoint inhibitors in breast cancer – Current status

(2018) Anne Polk et al.   CANCER TREATMENT REVIEWS

Targeting the androgen receptor in triple-negative breast cancer: current perspectives

(2017) Alain Mina et al.   OncoTargets and Therapy

Novel therapeutic strategies in the treatment of triple-negative breast cancer

(2017) Karima Oualla et al.   Therapeutic Advances in Medical Oncology

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

(2016) H. Bonnefoi et al.   ANNALS OF ONCOLOGY

The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair

(2016) Diana H. Liang et al.   CANCER LETTERS

Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer

(2016) Aiyu Zhu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells

(2016) Francesco Caiazza et al.   ENDOCRINE-RELATED CANCER

AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression

(2016) Yichun Qiao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer

(2016) MEISI YAN et al.   ONCOLOGY REPORTS

MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells

(2016) Gillian Browne et al.   TUMOR BIOLOGY

Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways

(2016) Ying-Min Wu et al.   Oncotarget

Tumor suppressor role of microRNA-1296 in triple-negative breast cancer

(2016) Binh Phan et al.   Oncotarget

Triple-negative breast cancer: is there a treatment on the horizon?

(2016) Hui Yao et al.   Oncotarget

Expression of Tumor-Related Macrophages and Cytokines After Surgery of Triple-Negative Breast Cancer Patients and its Implications

(2016) Jianguo Wang et al.   MEDICAL SCIENCE MONITOR

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

(2016) Brian D. Lehmann et al.   PLoS One

Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease

(2016) Valentina Cappello et al.   Scientific Reports

A systematic review of geographical variation in access to chemotherapy

(2015) Charlotte Chamberlain et al.   BMC CANCER

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer

(2015) B. D. Adams et al.   CANCER RESEARCH

Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo

(2015) V. N. Barton et al.   MOLECULAR CANCER THERAPEUTICS

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer

(2014) Jasmeet Chadha Singh et al.   BREAST CANCER RESEARCH

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

(2013) Lorella Maniscalco et al.   BMC Veterinary Research

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

(2013) Brian D Lehmann et al.   JOURNAL OF PATHOLOGY

Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

(2013) A. Prat et al.   ONCOLOGIST

A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index

(2013) Liang Huang et al.   PLoS One

VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer

(2012) S. Hart et al.   MOLECULAR CANCER THERAPEUTICS

Triple-negative breast cancer: are we making headway at least?

(2012) Monica Arnedos et al.   Therapeutic Advances in Medical Oncology

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

p53 as a Specific Prognostic Factor in Triple-negative Breast Cancer

(2009) B. J. Chae et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY